India’s drugmakers shake up global weight loss market with cheaper alternatives
However, questions remain over appropriate use and long-term effects. For 53-year-old IT engineer Sankari Roy, the shift could be significant. After being diagnosed with high blood sugar, she considered weight loss drugs like Ozempic and Wegovy. But at up to US$400 a month, the cost was prohibitive. Now, more affordable alternatives could provide her a new lifeline. "If I have…
Key Insights
- This topic is currently trending
- Experts are closely monitoring developments
- It may impact future decisions
